Timeline
Last
$186.47
-41.52 (-18.21%)
24HR-18.2%
1W-22.6%
1M-20.9%
1Y+32.7%
Valuation
- Market Cap
- $12B
- Enterprise Value
- $29.4B
- P/E (TTM)
- 18.48x
- Forward P/E
- 10.83x
- Price / Sales
- 0.87x
- EV / EBITDA
- 10.51x
Cash Flow
- Operating Cash Flow
- $2B
- Free Cash Flow
- $999.7M
- FCF Margin
- 7.2%
- Cash Conversion
- 49.3%
- Cash / Share
- $10.4
Margins & Growth
- Gross Margin
- 32.5%
- Operating Margin
- 13.9%
- EBITDA Margin
- 20.2%
- Net Margin
- 5.6%
- Revenue Growth
- 6.0%
- Earnings Growth
- 43.5%
Balance Sheet
- Total Cash
- $666.5M
- Total Debt
- $13.2B
- Net Cash
- -$12.6B
- Debt / Equity
- 12.61x
- Current Ratio
- 1.42x
- Quick Ratio
- 1.28x
Returns & Ownership
- Return on Assets
- 7.5%
- Return on Equity
- 81.0%
- Dividend Yield
- —
- Payout Ratio
- 0.0%
- Beta
- 0.87
- Institutional Ownership
- 52.9%
Latest EPS$2.87+0.2% surprise
Beat rate75%2 print streak
Avg surprise+0.0%vs consensus
Next printOct 28, 2026EPS $3.88
Quarterly EPS vs consensus
4 quarters Actual ConsensusLabels: beat $ · YoY %Revisions 13 up / 5 down
Earnings transcripts
Read management commentary and analyst Q&A.
No transcript dates are available yet for this ticker.
Forward estimates
Consensus expectations and estimate momentum.
PeriodEPSRevenueGrowth
0QJun 2026
$3.88$3.5B+31.6%+1QSep 2026
$3.92$3.5B+56.3%0YDec 2026
$14.88$14.1B+38.0%+1YDec 2027
$17.22$14.6B+15.7%Primary research
Recent company filings
Jump directly to earnings releases, quarterly reports, and material updates.
10-QPeriodic Financial Reports2026-08-048-KCorporate Changes & Voting Matters2026-06-0810-QPeriodic Financial Reports2026-05-0510-KPeriodic Financial Reports2026-02-118-KCorporate Changes & Voting Matters2026-02-028-KCorporate Changes & Voting Matters2025-11-258-KCorporate Changes & Voting Matters2025-10-298-KCorporate Changes & Voting Matters2025-08-208-KCorporate Changes & Voting Matters2025-08-058-KCorporate Changes & Voting Matters2025-07-178-KCorporate Changes & Voting Matters2025-06-098-KCorporate Changes & Voting Matters2025-05-23
DVA stock research · DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other p…
| Last price | $186.5 |
|---|---|
| Day change | -41.52 (-18.21%) |
| Market cap | $12B |
| P/E (TTM) | 18.48x |
| Sector | Healthcare |
| Industry | Medical Care Facilities |